EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ginkgo biloba L. as a Potential Alternative Therapy to Improve the Management of Diabetes: An Overview on Phytochemical Insights, Mechanisms, and Therapeutic Applications

Nawfal Hasan Siam, Nishat Anjum Talukder Eti, Afsana Akter Mim, Md Delwar Hossen, Tasnim Tabassum, Prottya Sarker, Taniza Tasnim, Irin Parvin, Jakir Ahmed Chowdhury

International Journal for Vitamin and Nutrition Research · 11.08.2025 · 95 (4)

DOI: 10.31083/ijvnr38103 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal for Vitamin and Nutrition Research, online erschienen am 11.08.2025. Verfasst von Nawfal Hasan Siam und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Pharmacy and Public Health, Independent University, Bangladesh (IUB), 1229 Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Ginkgo biloba, Hypoglycemic Agents, Diabetes Mellitus, Plant Extracts. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia and associated with severe complications, including cardiovascular diseases, neuropathy, nephropathy, and retinopathy. Although synthetic antidiabetic drugs are available, the side effects and limited long-term effectiveness of these medications highlight the urgent need for safer, more potent alternative therapies. Ginkgo biloba L., a traditional medicinal plant rich in flavonoids, terpenoids, and bilobalide, has attracted attention for its potential role in diabetes management. This review critically evaluates the antidiabetic potential of G. biloba by analyzing evidence from in vitro, in vivo, and clinical studies. Moreover, this review highlights the pharmacological actions of G. biloba and its key bioactive compounds, focusing on their mechanisms of action, including the activation of adenosine monophosphate-activated protein kinase (AMPK), the translocation of glucose transporter type 4 (GLUT4), and the inhibition of protein tyrosine phosphatases. The review also discusses the therapeutic implications of G. biloba supplementation and identifies gaps in clinical validation, optimal dosing, and safety profiling. Preclinical studies have demonstrated that G. biloba improves glycemic control by enhancing glucose uptake, regulating insulin secretion, inhibiting α-glucosidase activity, and exerting antioxidant and anti-inflammatory effects. Additionally, clinical trials suggest that supplementation with G. biloba can reduce oxidative stress, improve lipid profiles, and mitigate diabetes-related complications. However, despite these promising outcomes, inconsistencies remain in present study designs, dosages, and patient populations, which question the validity of results. Furthermore, studies related to the antidiabetic effect and underlying mechanisms of G. biloba, such as modulation of AMPK pathways and GLUT4 expression, also remain inadequate and warrant further systematic investigation. G. biloba may still be considered a complementary treatment approach in managing diabetes due to its broad pharmacological activities and favorable safety profile. However, well-designed, large-scale clinical trials are crucial for establishing standardized dosing regimens, confirming long-term safety, and fully elucidating the mechanisms of action. Integrating G. biloba into therapeutic strategies could offer a natural, and effective adjunct for enhancing glycemic control and reducing diabetes-related complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ginkgo bilobaHypoglycemic AgentsDiabetes MellitusPlant ExtractsPhytochemicalsPhytotherapyHumansAnimalsGlucose Transporter Type 4

Stichwörter der Autor:innen

G. bilobaactive compounddiabetesglucose metabolisminsulin resistance

Substanzen

Hypoglycemic AgentsPlant ExtractsPhytochemicalsGlucose Transporter Type 4

Autor:innen und Institutionen

  • Department of Pharmacy, School of Pharmacy and Public Health, Independent University, Bangladesh (IUB), 1229 Dhaka, Bangladesh.
  • Department of Medical Biotechnology, Faculty of Science, University of Technology Sydney (UTS), Sydney, NSW 2007, Australia.
  • Department of Biomedical Science, School of Health and Life Sciences, Teesside University, TS1 3BX Middlesbrough, UK.
  • Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, 1000 Dhaka, Bangladesh.

Zitieren

APA

Siam, N. H., Eti, N. A. T., Mim, A. A., Hossen, M. D., Tabassum, T., Sarker, P., Tasnim, T., Parvin, I., & Chowdhury, J. A. (2025). Ginkgo biloba L. as a Potential Alternative Therapy to Improve the Management of Diabetes: An Overview on Phytochemical Insights, Mechanisms, and Therapeutic Applications. International Journal for Vitamin and Nutrition Research, 95(4). https://doi.org/10.31083/ijvnr38103

Vancouver

Siam NH, Eti NAT, Mim AA, Hossen MD, Tabassum T, Sarker P, et al. Ginkgo biloba L. as a Potential Alternative Therapy to Improve the Management of Diabetes: An Overview on Phytochemical Insights, Mechanisms, and Therapeutic Applications. International Journal for Vitamin and Nutrition Research. 2025;95(4). doi:10.31083/ijvnr38103

BibTeX
@article{Siam2025,
  author = {Siam, Nawfal Hasan and Eti, Nishat Anjum Talukder and Mim, Afsana Akter and Hossen, Md Delwar and Tabassum, Tasnim and Sarker, Prottya and Tasnim, Taniza and Parvin, Irin and Chowdhury, Jakir Ahmed},
  title = {Ginkgo biloba L. as a Potential Alternative Therapy to Improve the Management of Diabetes: An Overview on Phytochemical Insights, Mechanisms, and Therapeutic Applications},
  journal = {International Journal for Vitamin and Nutrition Research},
  year = {2025},
  volume = {95},
  number = {4},
  doi = {10.31083/ijvnr38103}
}
Kostenlos starten →